Household transmission of SARS‐CoV‐2 during the Omicron wave in Shanghai, China: A case‐ascertained study

Author:

Wei Zhongqiu1,Ma Wenjie1,Wang Zhonglin1,Li Jingjing1,Fu Xiaomin1,Chang Hailing1,Qiu Yue1,Tian He1,Zhu Yanfeng1,Xia Aimei1,Wu Qianhui2,Liu Gongbao3,Zhai Xiaowen4,Zhang Xiaobo5,Wang Yan2,Zeng Mei16ORCID

Affiliation:

1. Department of Infectious Disease Children's Hospital of Fudan University Shanghai China

2. School of Public Health Fudan University, Key Laboratory of Public Health Safety, Ministry of Education Shanghai China

3. Department of Medicine Children's Hospital of Fudan University Shanghai China

4. Department of Hematology and Oncology Children's Hospital of Fudan University Shanghai China

5. Department of Respiratory Medicine Children's Hospital of Fudan University Shanghai China

6. Shanghai Institute of Infectious Disease and Biosecurity Fudan University Shanghai China

Abstract

AbstractObjectivesWe used a case‐ascertained study to determine the features of household transmission of SARS‐CoV‐2 Omicron variant in Shanghai, China.MethodsIn April 2022, we carried out a household transmission study from 309 households of 335 SARS‐CoV‐2 pediatric cases referred to a designated tertiary Children's Hospital. The detailed information can be collected from the 297 households for estimating the transmission parameters. The 236 households were qualified for estimating the secondary infection attack rates (SARI) and secondary clinical attack rates (SARC) among adult household contacts, characterizing the transmission heterogeneities in infectivity and susceptibility, and assessing the vaccine effectiveness.ResultsWe estimated the mean incubation period and serial interval of Omicron variant to be 4.6 ± 2.1 and 3.9 ± 3.7 days, respectively, with 57.2% of the transmission events occurring at the presymptomatic phase. The overall SARI and SARC among adult household contacts were 77.11% (95% confidence interval [CI]: 73.58%–80.63%) and 67.03% (63.09%–70.98%). We found higher household susceptibility in females. Infectivity was not significantly different between children and adults and symptomatic and asymptomatic cases. Two‐dose and booster‐dose of inactivated COVID‐19 vaccination were 14.8% (5.8%–22.9%) and 18.9% (9.0%–27.7%) effective against Omicron infection and 21.5% (10.4%–31.2%) and 24.3% (12.3%–34.7%) effective against the symptomatic disease.ConclusionsWe found high household transmission during the Omicron wave in Shanghai due to presymptomatic and asymptomatic transmission despite implementation of strict interventions, indicating the importance of early detection and timely isolation of SARS‐CoV‐2 infections. Marginal effectiveness of inactivated vaccines against Omicron infection poses a great challenge for outbreak containment.

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference44 articles.

1. World Health Organization.WHO Health Emergency Dashboard. Available at:https://covid19.who.int/. Accessed 6 July 2022.

2. World Health Organization.Weekly epidemiological update on COVID‐19‐1 March 2022. Available from:https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-march-2022. Accessed 31 March 2022.

3. World Health Organization.Enhancing response to Omicron SARS‐CoV‐2 variant: Technical brief and priority actions for Member States. Available at:https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states. Accessed 22 April 2022.

4. The Dynamic COVID-Zero Strategy in China

5. National Health Commission of The People's Republic of China.Technical guideline for COVID‐19 vaccination (the first version). 29March 2021. Available from:http://www.nhc.gov.cn/jkj/s3582/202103/c2febfd04fc5498f916b1be080905771.shtml. Accessed 22 April 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3